Financhill
Sell
32

MVMDF Quote, Financials, Valuation and Earnings

Last price:
$0.01
Seasonality move :
-18.16%
Day range:
$0.01 - $0.01
52-week range:
$0.01 - $0.03
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
145.58x
P/B ratio:
5.15x
Volume:
2.6K
Avg. volume:
26.4K
1-year change:
-17.86%
Market cap:
$4.9M
Revenue:
$35.2K
EPS (TTM):
-$0.01

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Mountain Valley MD Holdings, Inc. has -- downside to fair value with a price target of -- per share.

MVMDF vs. S&P 500

  • Over the past 5 trading days, Mountain Valley MD Holdings, Inc. has underperformed the S&P 500 by -12.06% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Mountain Valley MD Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Mountain Valley MD Holdings, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Mountain Valley MD Holdings, Inc. reported revenues of --.

Earnings Growth

  • Mountain Valley MD Holdings, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Mountain Valley MD Holdings, Inc. reported earnings per share of -$0.00.
Enterprise value:
4.5M
EV / Invested capital:
--
Price / LTM sales:
145.58x
EV / EBIT:
--
EV / Revenue:
135.32x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.49x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$88.8K
Return On Assets:
-116.82%
Net Income Margin (TTM):
-15624.85%
Return On Equity:
-120.4%
Return On Invested Capital:
-120.4%
Operating Margin:
-2394.68%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- $64.5K $33.5K -- --
Gross Profit -$318K -$167.4K -$88.8K -$44.7K -$16K
Operating Income -$3.1M -$2.8M -$2.3M -$440.6K -$441.4K
EBITDA -$2.7M -$2.6M -$2.1M -$395.9K -$425.5K
Diluted EPS -$0.01 -$0.02 -$0.01 -$0.00 -$0.00
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $14.1M $9.8M $6.8M $4.9M $455.7K
Total Assets $21.9M $15.3M $11.4M $6.6M $1M
Current Liabilities $507.6K $523.3K $234.5K $177.7K $58.2K
Total Liabilities $536K $527.6K $234.5K $177.7K $58.2K
Total Equity $21.4M $14.8M $11.1M $6.5M $943.7K
Total Debt $50.5K $18.2K -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$3.2M -$3.1M -$1.8M -$791.8K -$380.1K
Cash From Investing $768.6K -$206.1K $200 -- --
Cash From Financing -$1.2M -$4.4K -- -- --
Free Cash Flow -$3.6M -$3.1M -- -$791.8K --
MVMDF
Sector
Market Cap
$4.9M
--
Price % of 52-Week High
51.11%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-17.86%
--
Beta (5-Year)
0.986
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.01
200-day SMA
Sell
Level $0.02
Bollinger Bands (100)
Sell
Level 0.01 - 0.01
Chaikin Money Flow
Buy
Level 2.3M
20-day SMA
Sell
Level $0.01
Relative Strength Index (RSI14)
Buy
Level 51.88
ADX Line
Sell
Level 38.4
Williams %R
Neutral
Level -22.8916
50-day SMA
Sell
Level $0.01
MACD (12, 26)
Sell
Level 0.00
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level 1.5M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-10.434)
Sell
CA Score (Annual)
Level (-1.1423)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (68.414)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Mountain Valley MD Holdings, Inc. is a biotech company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into product formats that, if successfully commercialized, could enhance the efficacy of molecule delivery across a variety of nutraceutical product applications. The Quicksol™ patented is a solubilization technology, which has been developed to provide solubilized drug delivery options. The company was founded on March 8, 2005 and is headquartered in Vaughan, Canada.

Stock Forecast FAQ

In the current month, MVMDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MVMDF average analyst price target in the past 3 months is --.

  • Where Will Mountain Valley MD Holdings, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Mountain Valley MD Holdings, Inc. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Mountain Valley MD Holdings, Inc.?

    Analysts are divided on their view about Mountain Valley MD Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mountain Valley MD Holdings, Inc. is a Sell and believe this share price will rise from its current level to --.

  • What Is Mountain Valley MD Holdings, Inc.'s Price Target?

    The price target for Mountain Valley MD Holdings, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MVMDF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Mountain Valley MD Holdings, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MVMDF?

    You can purchase shares of Mountain Valley MD Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mountain Valley MD Holdings, Inc. shares.

  • What Is The Mountain Valley MD Holdings, Inc. Share Price Today?

    Mountain Valley MD Holdings, Inc. was last trading at $0.01 per share. This represents the most recent stock quote for Mountain Valley MD Holdings, Inc.. Yesterday, Mountain Valley MD Holdings, Inc. closed at $0.01 per share.

  • How To Buy Mountain Valley MD Holdings, Inc. Stock Online?

    In order to purchase Mountain Valley MD Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 2.06% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 0.21% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock